Show Summary Details

Quick Reference

An inhibitor of platelet aggregation that irreversibly inhibits the P2Y12 ADP receptor and blocks activation of the glycoprotein GPIIb/IIIa complex. Used as an antithrombotic. TN Plavix.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.